JP2024100792A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2024100792A5 JP2024100792A5 JP2024074707A JP2024074707A JP2024100792A5 JP 2024100792 A5 JP2024100792 A5 JP 2024100792A5 JP 2024074707 A JP2024074707 A JP 2024074707A JP 2024074707 A JP2024074707 A JP 2024074707A JP 2024100792 A5 JP2024100792 A5 JP 2024100792A5
- Authority
- JP
- Japan
- Prior art keywords
- ppm
- compound
- crystalline polymorph
- solid
- magnetic resonance
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962841401P | 2019-05-01 | 2019-05-01 | |
| US62/841,401 | 2019-05-01 | ||
| JP2021563717A JP7513349B2 (ja) | 2019-05-01 | 2020-04-30 | ＧｌｙＴ１阻害剤の固体形態 |
| PCT/US2020/030580 WO2020223419A1 (en) | 2019-05-01 | 2020-04-30 | Solid forms of a glyt1 inhibitor |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021563717A Division JP7513349B2 (ja) | 2019-05-01 | 2020-04-30 | ＧｌｙＴ１阻害剤の固体形態 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024100792A JP2024100792A (ja) | 2024-07-26 |
| JP2024100792A5 true JP2024100792A5 (https=) | 2024-08-13 |
| JP7714727B2 JP7714727B2 (ja) | 2025-07-29 |
Family
ID=70740812
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021563717A Active JP7513349B2 (ja) | 2019-05-01 | 2020-04-30 | ＧｌｙＴ１阻害剤の固体形態 |
| JP2024074707A Active JP7714727B2 (ja) | 2019-05-01 | 2024-05-02 | ＧｌｙＴ１阻害剤の固体形態 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021563717A Active JP7513349B2 (ja) | 2019-05-01 | 2020-04-30 | ＧｌｙＴ１阻害剤の固体形態 |
Country Status (25)
| Country | Link |
|---|---|
| US (2) | US11447474B2 (https=) |
| EP (1) | EP3962911A1 (https=) |
| JP (2) | JP7513349B2 (https=) |
| KR (1) | KR20220004174A (https=) |
| CN (1) | CN113784966B (https=) |
| AR (1) | AR118839A1 (https=) |
| AU (1) | AU2020266566B2 (https=) |
| BR (1) | BR112021020883A2 (https=) |
| CA (1) | CA3138288A1 (https=) |
| CL (2) | CL2021002837A1 (https=) |
| CO (1) | CO2021014260A2 (https=) |
| CR (1) | CR20210545A (https=) |
| DO (1) | DOP2021000224A (https=) |
| EA (1) | EA202192925A1 (https=) |
| EC (1) | ECSP21082195A (https=) |
| IL (1) | IL287630A (https=) |
| JO (1) | JOP20210295A1 (https=) |
| MA (1) | MA55801A (https=) |
| MX (1) | MX2021013341A (https=) |
| PE (1) | PE20212263A1 (https=) |
| PH (1) | PH12021552741A1 (https=) |
| SG (1) | SG11202111972YA (https=) |
| TW (1) | TW202106680A (https=) |
| UA (1) | UA129159C2 (https=) |
| WO (1) | WO2020223419A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7930336B2 (en) | 2006-12-05 | 2011-04-19 | Altera Corporation | Large multiplier for programmable logic device |
| EA202192925A1 (ru) * | 2019-05-01 | 2022-03-23 | Бёрингер Ингельхайм Интернациональ Гмбх | Твердые формы ингибитора glyt1 |
| US11813257B2 (en) | 2020-01-09 | 2023-11-14 | Disc Medicine, Inc. | Methods of treating erythropoietic protoporphyria, X-linked protoporphyria, or congenital erythropoietic porphyria with glycine transport inhibitors |
| MX2023001818A (es) * | 2020-08-13 | 2023-03-13 | Boehringer Ingelheim Int | Compuestos para usarse en tratamiento de deterioro cognitivo asociado con la esquizofrenia. |
| IL301829A (en) | 2020-10-13 | 2023-06-01 | Boehringer Ingelheim Int | Process of reworking |
| WO2025140479A1 (zh) * | 2023-12-29 | 2025-07-03 | 苏州科睿思制药有限公司 | Iclepertin的晶型及其制备方法和用途 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL65843A (en) * | 1977-08-11 | 1986-12-31 | American Cyanamid Co | Pharmaceutical compositions for the treatment of depression containing 3-aza-bicyclo(3.1.0)hexane derivatives and certain novel compounds of this type |
| RS20060190A (sr) * | 2003-10-14 | 2008-08-07 | Pfizer Products Inc., | Biciklični /3.1.0/ derivati kao inhibitori transportera glicina |
| CA2745690A1 (en) * | 2008-12-04 | 2010-06-10 | Evgeny Zlotinikov | Novel polymorphic forms of an azabicyclo-trifluoromethyl benzamide derivative |
| EP2381941A4 (en) * | 2008-12-29 | 2012-08-01 | Univ Vanderbilt | 3.1.0 BICYCLIC GLYTI INHIBITORS AND METHOD FOR THE PRODUCTION AND USE THEREOF |
| US9012489B2 (en) | 2011-08-03 | 2015-04-21 | Boehringer Ingelheim International Gmbh | Phenyl-3-aza-bicyclo[3.1.0]hex-3-yl-methanones and the use thereof as medicament |
| IL270155B (en) * | 2017-04-27 | 2022-07-01 | Takeda Pharmaceuticals Co | Heterocyclic compound |
| EA202192925A1 (ru) * | 2019-05-01 | 2022-03-23 | Бёрингер Ингельхайм Интернациональ Гмбх | Твердые формы ингибитора glyt1 |
| MX2023001818A (es) * | 2020-08-13 | 2023-03-13 | Boehringer Ingelheim Int | Compuestos para usarse en tratamiento de deterioro cognitivo asociado con la esquizofrenia. |
| IL301829A (en) * | 2020-10-13 | 2023-06-01 | Boehringer Ingelheim Int | Process of reworking |
-
2020
- 2020-04-30 EA EA202192925A patent/EA202192925A1/ru unknown
- 2020-04-30 TW TW109114685A patent/TW202106680A/zh unknown
- 2020-04-30 PE PE2021001800A patent/PE20212263A1/es unknown
- 2020-04-30 EP EP20726654.5A patent/EP3962911A1/en active Pending
- 2020-04-30 DO DO2021000224A patent/DOP2021000224A/es unknown
- 2020-04-30 WO PCT/US2020/030580 patent/WO2020223419A1/en not_active Ceased
- 2020-04-30 AU AU2020266566A patent/AU2020266566B2/en active Active
- 2020-04-30 PH PH1/2021/552741A patent/PH12021552741A1/en unknown
- 2020-04-30 KR KR1020217039503A patent/KR20220004174A/ko not_active Ceased
- 2020-04-30 UA UAA202106566A patent/UA129159C2/uk unknown
- 2020-04-30 CA CA3138288A patent/CA3138288A1/en active Pending
- 2020-04-30 JP JP2021563717A patent/JP7513349B2/ja active Active
- 2020-04-30 SG SG11202111972YA patent/SG11202111972YA/en unknown
- 2020-04-30 JO JOP/2021/0295A patent/JOP20210295A1/ar unknown
- 2020-04-30 CN CN202080032902.7A patent/CN113784966B/zh active Active
- 2020-04-30 CR CR20210545A patent/CR20210545A/es unknown
- 2020-04-30 US US16/862,608 patent/US11447474B2/en active Active
- 2020-04-30 BR BR112021020883A patent/BR112021020883A2/pt unknown
- 2020-04-30 AR ARP200101242A patent/AR118839A1/es unknown
- 2020-04-30 MA MA055801A patent/MA55801A/fr unknown
- 2020-04-30 MX MX2021013341A patent/MX2021013341A/es unknown
-
2021
- 2021-10-26 CO CONC2021/0014260A patent/CO2021014260A2/es unknown
- 2021-10-27 IL IL287630A patent/IL287630A/en unknown
- 2021-10-28 CL CL2021002837A patent/CL2021002837A1/es unknown
- 2021-11-17 EC ECSENADI202182195A patent/ECSP21082195A/es unknown
-
2022
- 2022-06-27 US US17/849,935 patent/US20220332710A1/en not_active Abandoned
-
2024
- 2024-03-21 CL CL2024000829A patent/CL2024000829A1/es unknown
- 2024-05-02 JP JP2024074707A patent/JP7714727B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024100792A5 (https=) | ||
| KR102807521B1 (ko) | 2종의 4-｛[(2s)-2-｛4-[5-클로로-2-(1h-1,2,3-트리아졸-1-일)페닐]-5-메톡시-2-옥소피리딘-1(2h)-일}부타노일]아미노}-2-플루오로벤즈아미드 유도체의 제조 방법 | |
| CN1227233C (zh) | 纯晶形的5－氯－3－(4－甲磺酰基苯基)－6′－甲基－[2,3′]联吡啶及其合成方法 | |
| HK1049002A1 (en) | Method for the preparation of citalopram | |
| UA71635C2 (uk) | Спосіб одержання чистого циталопраму | |
| JP2024095561A5 (https=) | ||
| CN1041933C (zh) | 克拉维酸的二胺盐及其制备方法和用途 | |
| CN103664805A (zh) | 一种制备阿昔莫司的方法 | |
| JP5984988B2 (ja) | （＋）および（−）−１−（３，４−ジクロロフェニル）−３−アザビシクロ［３．１．０］ヘキサンの合成のための方法 | |
| CN108285436B (zh) | 一种ae-活性酯的制备工艺 | |
| JP6148351B2 (ja) | 置換ピロリジン−２−カルボキサミドの不斉合成 | |
| CN115181105A (zh) | R型酮咯酸的制备方法及其应用 | |
| CN104557583A (zh) | 一种合成γ-氨基丁酸类手性化合物的方法 | |
| WO2012041263A2 (en) | A method of manufacturing 2-({(5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]- l,3-oxazolidin-5-yl}methyl)-lh-isoindol-l,3(2h)-dione with a high optical purity | |
| CN111303040A (zh) | 一种一锅法制备咪唑-1-乙酸的方法 | |
| CN107879979B (zh) | 一种右美托咪定的制备方法 | |
| CN1629153A (zh) | 西酞普兰中间体晶体碱 | |
| JP2617960B2 (ja) | 光学活性カルボン酸をつくる立体異性化方法 | |
| JP2024515770A5 (https=) | ||
| CN120157629B (zh) | 一种吗啉酮衍生物的合成工艺 | |
| CN113603634B (zh) | 一种阿扎那韦中间体的制备方法 | |
| KR102134179B1 (ko) | 카보네이트를 이용한 시탈로프람 및 에스시탈로프람의 새로운 제조 방법 | |
| WO2006025071A1 (en) | A process for the preparation of escitalopram | |
| JP6622634B2 (ja) | ミルタザピンの製造方法 | |
| JP2026505630A (ja) | イソオキサゾリン誘導体を調製する方法 |